Treprostinil sodium is the sodium salt of treprostinil, a chemically stable prostacyclin analogue used mainly to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It is grouped under the following drug class(es): Prostaglandins and Vasodilating agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Remodulin and Yutrepia. Its PubChem CID is 23663413.
Treprostinil sodium
| CAS No | 289480-64-4 |
|---|---|
| Molecular Formula | C23H33NaO5 |
| Molecular Weight | 412.5 g/mol |
| Synonyms | sodium 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Treprostinil sodium is the sodium salt of treprostinil, a chemically stable prostacyclin analogue used mainly to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
The listed CAS number is 289480-64-4.
The listed molecular formula is C23H33NaO5.
The listed molecular weight is 412.5 g/mol.
sodium 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate.
The source lists Remodulin and Yutrepia.